# FDA Inspection 563761 - Massachusetts General Hospital - February 11, 2009

Source: https://www.globalkeysolutions.net/records/fda_inspections/massachusetts-general-hospital/498e6e03-04d3-4321-a79a-63a3f4f6c565
Source feed: FDA_Inspections

> FDA Inspection 563761 for Massachusetts General Hospital on February 11, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 563761
- Company Name: Massachusetts General Hospital
- Inspection Date: 2009-02-11
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1042063 - 2018-01-31](https://www.globalkeysolutions.net/records/fda_inspections/massachusetts-general-hospital/749d55ed-152d-4504-893d-2e1e0237b8ba)
- [FDA Inspection 999897 - 2017-01-24](https://www.globalkeysolutions.net/records/fda_inspections/massachusetts-general-hospital/be6e6615-205e-4c08-b891-254ae3216798)
- [FDA Inspection 833328 - 2013-05-14](https://www.globalkeysolutions.net/records/fda_inspections/massachusetts-general-hospital/f458c663-2f56-49ed-b22c-e7b44a502295)

Company: https://www.globalkeysolutions.net/companies/massachusetts-general-hospital/80f6c448-fbde-4675-bb43-1151f2e85c4b

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d